Analysis reveals changing dengue patterns and emphasizes vaccines and therapies to reduce risk in vulnerable populations, suggesting an integrated approach.
Climate change and human-related factors are driving the global expansion of dengue risk, including in temperate regions. While licensed vaccines offer new prevention opportunities, limitations remain, especially for vulnerable populations. Continued research into effective antivirals and innovative vaccines is critical. A multidisciplinary approach integrating vector control, vaccination, and emerging therapies is essential to address the growing dengue burden in a warming world.
No takes yet. Share an insight, caveat, or question.
Norman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: